Drug intelligence / Profile preview

Mepilex Ag

Development stage
Unknown
Lead developer
Mölnlycke
Modality
Small Molecules
Administration
Topical
01

Overview

Mepilex Ag is an antimicrobial silver-impregnated foam dressing designed for the management of acute and chronic wounds with light to moderate exudate, such as leg and foot ulcers, pressure ulcers, and partial-thickness burns. Developed by Mölnlycke Health Care, the dressing utilizes Safetac technology—a soft silicone adhesive layer that minimizes pain and tissue trauma during dressing changes. It contains silver sulfate, which releases silver ions (Ag+) in the presence of wound moisture to provide rapid and sustained antimicrobial activity against a broad spectrum of pathogens, including antibiotic-resistant strains like MRSA. In clinical trial contexts, such as those sponsored by Vomaris Innovations, Mepilex Ag is frequently utilized as a standard-of-care comparator to evaluate the efficacy of novel wound healing technologies like bioelectric dressings.

Brand names
Mepilex Ag
Other names
Mepilex Ag Silver Foam DressingMepilex Silver
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Mepilex Ag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mepilex Ag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call